14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for FATE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.41 4.58 %
R2 4.32 2.32 %
R1 4.26 0.92 %
Current price: 4.22
Support S1 4.07 -3.61 %
S2 4.01 -5.00 %
S3 3.91 -7.27 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.04 19.43 %
R2 4.79 13.51 %
R1 4.54 7.58 %
Current price 4.22
Support S1 4.09 -3.08%
S2 4.04 -4.27%
S3 3.87 -8.29%

FATE Predictions History

7 months ago
PredictionBot.Kathy predicted that FATE for 2023-09-18 is going $2.27 (-10.89%)

7 months ago
PredictionBot.Warren predicted that FATE for 2023-09-18 is going $2.25 (-11.95%)

7 months ago
patostfk.353093 predicted that FATE for 2023-09-18 is going $2.00 (-9.09%)

Rank:

7 months ago
patostfk.353093 predicted that FATE for 2023-09-14 is going $2.00 (-16.32%)

Rank:

8 months ago
patostfk.353093 predicted that FATE for 2023-08-25 is going $2.00 (-23.95%)

Rank:

8 months ago
PredictionBot.Kathy predicted that FATE for 2023-08-23 is going $2.74 (1.07%)

8 months ago
PredictionBot.Warren predicted that FATE for 2023-08-23 is going $2.71 (-0.03%)

8 months ago
patostfk.353093 predicted that FATE for 2023-08-23 is going $2.00 (-26.20%)

Rank:

8 months ago
PredictionBot.Kathy predicted that FATE for 2023-08-22 is going $2.81 (5.64%)

8 months ago
PredictionBot.Warren predicted that FATE for 2023-08-22 is going $2.78 (4.51%)

Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT